| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/22/2007 | EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1534807B1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 08/22/2007 | EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer |
| 08/22/2007 | CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
| 08/22/2007 | CN101022853A Mixture of catechins or polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH) |
| 08/22/2007 | CN101020044A Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 08/22/2007 | CN101020040A Chinese medicine for treating hepatorenal syndrome |
| 08/22/2007 | CN101020033A Medicine for treating renal calculus |
| 08/22/2007 | CN101020015A Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia |
| 08/22/2007 | CN101019986A Health food for preventing and treating prostatosis and its prepn |
| 08/22/2007 | CN101019958A Total effective component of Chinese lizardtail herb and its prepn process and medicinal application |
| 08/22/2007 | CN101019942A Chinese medicine for treating urinary tract infection |
| 08/22/2007 | CN101019937A Medicine for treating renal calculus and its prepn process |
| 08/22/2007 | CN101019934A Chinese medicine composition for treating renal failure and its prepn process |
| 08/22/2007 | CN101019933A Chinese medicine composition and its prepn process |
| 08/22/2007 | CN101019892A Solid pipefish dispersion and its prepn and application |
| 08/22/2007 | CN101019848A Application of ferricitras in preparation of medicine to prevent and treat angiosteosis |
| 08/22/2007 | CN101019627A Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 08/21/2007 | US7259181 β crystalline form of perindopril tert-butylamine salt |
| 08/21/2007 | US7259170 Macrolides containing pharmaceutical compositions |
| 08/21/2007 | US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders |
| 08/21/2007 | US7259152 Oral administration of Sulodexide in unit dosages suitable for the treatment of diabetic nephropathies in both macro and micro albuminic patients, producing immediate and lasting improvement in albumin excretion rate |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007074291A3 Incontinence treatment methods |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190053 Treament of lupus nephritis with anti-CD40L compounds |
| 08/16/2007 | US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 08/16/2007 | DE20221760U1 Verwendung von Seltenerdverbindungen zur Prävention von Nierensteinerkrankung Use of rare earth compounds for the prevention of kidney stone disease |
| 08/16/2007 | CA2637817A1 Vitamin d analog - nel, methods and uses thereof |
| 08/16/2007 | CA2637302A1 Vitamin d analog-rak, methods and uses thereof |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817040A2 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 08/15/2007 | EP1613327B1 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug |
| 08/15/2007 | EP1594516B1 Herbal compositions for prostate conditions |
| 08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
| 08/15/2007 | EP1534715B1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | EP1259242B1 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/15/2007 | CN1331857C Fused-polycyclic compounds |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331499C Health-care medicated wines with reinforcing-kidney and nourishing yin and strong then yang function, and its prepn. method |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101015693A Use of CD25 binding molecules in steroid-resistant patients. |
| 08/15/2007 | CN101015681A Medicine for treating chronic renal failure and its preparing process |
| 08/15/2007 | CN101015662A Medicine for treating prostatosis and method for preparing same |
| 08/15/2007 | CN101015623A Medicine for treating chronic nephritis and its preparing process |
| 08/15/2007 | CN101015588A Medicine for treating nephritis |
| 08/15/2007 | CN101015313A Lotus-leaf lotus-plumule herb tea |
| 08/15/2007 | CN101015312A Health care functional tea for conditioning subhealthy state |
| 08/15/2007 | CN101015310A Lotus-leaf lotus-plumule tea |
| 08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256188 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists |
| 08/14/2007 | US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | CA2421302C 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/14/2007 | CA2281708C Process for preparing eprosartan |
| 08/14/2007 | CA2251016C .alpha.1-adrenergic receptor antagonists |
| 08/14/2007 | CA2223414C Heteroaryl diol acids as leukotriene antagonists |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007089031A1 Piperidine derivatives as tachykinin receptor antagonists |
| 08/09/2007 | WO2007088704A1 Preventive/remedy for urinary calculosis |
| 08/09/2007 | WO2007088190A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 08/09/2007 | WO2007054269A3 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 08/09/2007 | US20070185195 Hyperuricemia; uricosuric agents, which have potent uricosuric effect and do not cause grave hepatic disorder; against the uptake of uric acid in kidney |
| 08/09/2007 | US20070185020 Methods and compositions for treating disorders of the extracellular matrix |
| 08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184116 Pharmaceutical formulation containing unmilled flutamide |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |